
|Articles|April 1, 2004
No adverse consequences to infants' long-term probiotic use
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves linaclotide (Linzess) for pediatric patients aged 7 years and older with IBS-C
2
Health system–based clinical pathway improves pediatric lipid screening rates
3
Wesley Kufel, PharmD, discusses doxycycline for post-exposure prevention of Lyme disease in young children
4
Silvana Bonilla, MD, discusses geographic patterns of H. Pylori in pediatric digestive disease
5














